Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adial Pharmaceuticals Inc (NQ: ADIL )

2.180 USD UNCHANGED
Streaming Delayed Price Updated: 6:59 PM EDT, Apr 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.180
Bid (Size) 2.070 (10)
Ask (Size) 2.700 (1)
Prev. Close 2.180
Today's Range 2.180 - 2.180
52wk Range 1.140 - 4.000
Shares Outstanding 5,474,856
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Adial Founder and Chief Medical Officer Dr. Bankole Johnson Featured Guest on The Black News Channel
March 17, 2021
Discusses long-term effects of COVID-19 pandemic on mental health and addiction 
From GlobeNewswire News Releases
Adial Announces Management-Led $2,100,000 Above Market Private Placement at $3.00 Per Share
March 15, 2021
From GlobeNewswire News Releases

Performance

YTD
+26.01%
+26.01%
1 Month
-19.26%
-19.26%
3 Month
+5.31%
+5.31%
6 Month
+10.10%
+10.10%
1 Year
+77.24%
+77.24%

More News

Read More
Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion
February 26, 2021
From GlobeNewswire News Releases
Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants
February 26, 2021
From GlobeNewswire News Releases
Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD™ Phase 3 Trial
February 25, 2021
From GlobeNewswire News Releases
Adial to File Fast Track Application for AD04 with the FDA
February 23, 2021
From GlobeNewswire News Releases
Adial Pharmaceuticals Closes Acquisition of Purnovate
January 26, 2021
From ACCESSWIRE
Adial Pharmaceuticals to Present at 23rd Annual ICR Conference
January 11, 2021
From ACCESSWIRE
Adial Pharmaceuticals Receives Notice of Allowance for Third U.S. Patent Covering AD04 for the Treatment for Opioid Use Disorder
January 11, 2021
From ACCESSWIRE
Adial Pharmaceuticals Appoints Dr. Jack Reich as Head of Regulatory
December 15, 2020
From ACCESSWIRE
Adial Pharmaceuticals Schedules Business Update Conference Call to Discuss Planned Acquisition of Purnovate and other Recent Developments
December 10, 2020
From ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media